Clinical Roundup NCCN adds information on third mRNA COVID-19 vaccine to guidance for cancer patients September 03, 2021Vol.47 No.32
Clinical Roundup JNCCN study reveals neuroendocrine tumor mortality patterns to inform treatment decisions September 03, 2021Vol.47 No.32
Clinical Roundup Adult brain tumor incidence rates are decreasing but five-year survival rates remain low September 03, 2021Vol.47 No.32
Clinical Roundup City of Hope study suggests adding the drug berzosertib to standard treatment for metastatic bladder cancer does not benefit patients September 03, 2021Vol.47 No.32
Clinical Roundup Yale Cancer Center report highlights NSCLC treatment advances September 03, 2021Vol.47 No.32
Drugs & Targets FDA requires monitoring of long-term clinical outcomes for robotic surgery in breast cancer September 03, 2021Vol.47 No.32
Drugs & Targets Tibsovo receives FDA approval for advanced or metastatic cholangiocarcinoma September 03, 2021Vol.47 No.32
Drugs & Targets Opdivo receives FDA approval for adjuvant treatment of urothelial carcinoma September 03, 2021Vol.47 No.32
Drugs & Targets Jemperli receives FDA accelerated approval for dMMR advanced solid tumors September 03, 2021Vol.47 No.32
